Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 5 (2008), Issue 2 (February)

1. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
   Neurology, 70(6): 440-8. [Abstract] [Full-text]
2. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.
   J Am Geriatr Soc, 56(2): 239-46. [Abstract] [Full-text]
3. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.
   J Neurosci, 28(6): 1410-20. [Abstract] [Full-text]
4. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
   Nature, 451(7179): 720-4. [Abstract] [Full-text]
5. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
   Neurology, 70(7): 512-20. [Abstract] [Full-text]
6. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.
   J Neurosci, 28(7): 1537-45. [Abstract] [Full-text]
7. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease.
   Hum Mol Genet, 17(5): 759-67. [Abstract] [Full-text]
8. S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease.
   Neurobiol Aging, 29(3): 478-80. [Abstract] [Full-text]
9. Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.
   Neurobiol Aging, 29(3): 348-56. [Abstract] [Full-text]
10. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    J Neurochem, 104(5): 1249-59. [Abstract] [Full-text]
11. Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity.
    Proc Natl Acad Sci U S A, 105(7): 2681-6. [Abstract] [Full-text]
12. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    J Neurochem, 104(5): 1333-44. [Abstract] [Full-text]
13. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Biol Psychiatry, 63(6): 609-18. [Abstract] [Full-text]
14. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease.
    CMAJ, 178(5): 548-56. [Abstract] [Full-text]
15. Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype.
    Stroke, 39(3): 814-21. [Abstract] [Full-text]
16. The GSK3 hypothesis of Alzheimer's disease.
    J Neurochem, 104(6): 1433-9. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.